Filing Flows › ASP Isotopes (ASPI) › Q2 2026
ASP Isotopes (ASPI) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
ASP Isotopes (ASPI) reported revenue of $5.1M for the second quarter 2026 (Q2 2026), +328% from a year earlier and +23% from the quarter before. Operating margin was -667.5%, net loss $34.0M (663.5% of revenue).
ASP Isotopes, Q2 2026: revenue $5.1M (+328% year over year), operating margin -667.5%, net loss $34.0M, operating cash flow −$23.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.1M | +23% | +328% |
| Operating profit | −$34.2M | — | — |
| Net earnings | −$34.0M | — | — |
| Operating cash flow | −$23.3M | — | — |
What changed
Revenue was $5.1M in Q2 2026, up 328% year over year and up 23% from the previous quarter. Product was the largest line at 88% of revenue. Product added $3.3M year over year (up 278%), 85% of the total change.
Gross margin was 28.9%, down 18.9 points from Q2 2025. Operating costs exceeded revenue by $34.2M, an operating margin of -667.5%. Operating expenses grew 184% against revenue growth of 328%. The fastest-growing cost line was Research & development (+675%). The quarter ended with a net loss of $34.0M, wider than the previous quarter's $7.1M loss.
Operating cash flow was −$23.3M. Non-cash charges added back $1.2M of depreciation and amortization and $4.5M of share-based compensation. Working capital and other items added $4.9M. Capital expenditures of $4.1M exceeded it, leaving free cash flow of −$27.4M.
Questions
What was ASP Isotopes' revenue in the second quarter 2026?
ASP Isotopes (ASPI) reported revenue of $5.1M for the second quarter 2026 (Q2 2026), +328% from a year earlier and +23% from the quarter before.
Was ASP Isotopes profitable in the second quarter 2026?
Operating loss was $34.2M (-667.5% of revenue) and net loss $34.0M.
Source: ASP Isotopes 10-Q on SEC EDGAR.